Skip to main content

Animations

MJFF Publications

4821 - 4830 of 8825 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2019
  • 2021
  • 2025
  • 2021
  • 2022
  • 2023
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2019.01.011
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies
    Journal Name: Journal of Molecular Cell Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jmcb/mjaa075
    Citation Count: 101
  • Summary Details
    OPEN
    Title: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1002/mds.28641
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Hexokinase 2 interacts with PINK1 to facilitate mitophagy in astrocytes and restrain inflammation-induced neurotoxicity
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115809
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
    Journal Name: Clinical Chemistry and Laboratory Medicine (CCLM)
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1515/cclm-2020-1521
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s disease
    Journal Name: Medizinische Genetik
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1515/medgen-2022-2127
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/ejn.15917
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment Questionnaire
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1002/mds.28507
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Replication of a Novel Parkinson's Locus in a European Ancestry Population
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28546
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.